Key Highlights

  • 9.25% is the move in Alignment Healthcare, Inc. (NASDAQ:ALHC) in today's session on November 18, 2026, taking the traded price to USD 6.92 from a calculated prior close of USD 7.63, a calculated USD 0.71 drop.
  • 1.16M shares traded in Alignment Healthcare, Inc. today, after a flat 0.00% gap at the open and a further 9.25% decline since the open, implying an opening price near the calculated prior close of USD 7.63.
  • 301,200 is the health plan membership reported for the third quarter of 2026, up 31.2%, while total Revenue rose 36.7% to USD 1,358.3 million and adjusted EBITDA fell 32.8% to USD 21.8 million.
  • 305,000 is the minimum full-year 2026 health plan membership guided by the company, alongside minimum revenue of USD 5,245 million, adjusted EBITDA of USD 100 million and a fourth-quarter adjusted EBITDA loss of USD 28 million.

What Moved Alignment Healthcare, Inc. (NASDAQ:ALHC) in Trading on November 18, 2026 (-USD 0.71, -9.25%)

The traded price of Alignment Healthcare, Inc. (NASDAQ:ALHC) in today's session on November 18, 2026 is USD 6.92, a move of -9.25% on Volume of 1.16M shares. On a calculated basis the prior close was USD 7.63 (USD 6.92 divided by 0.9075) and the USD move is -USD 0.71 (price minus prior close). The shares opened at the prior close, a 0.00% gap, then traded 9.25% below the open, so the entire decline came during the regular session. A corroborated market Capitalization and share count were not found.

The Rationale: No Identified Catalyst After the Lowered Outlook for Alignment Healthcare, Inc. (NASDAQ:ALHC)

No catalyst for the November 18, 2026 move was identified in published coverage. The most recent company event was the third quarter release on October 29, 2026, in which the company raised full-year membership and revenue guidance but lowered adjusted Gross Profit and adjusted EBITDA guidance. Chief executive John Kao said the company was taking a prudent approach to the fourth quarter and lowering its outlook based on current headwinds. The adjusted medical benefits ratio rose about 240 basis points to 89.5%. As general context, managed care shares often react to cost-trend and rating headlines across the sector.

Valuation, Liquidity and Risks for Alignment Healthcare, Inc. (NASDAQ:ALHC)

The latest reported period is the third quarter ended September 30, 2026, released October 29, 2026. Total revenue was USD 1,358.3 million, up 36.7%, with a net loss of USD 8.1 million (USD 0.04 per share) against Net Income of USD 3.7 million a year earlier and a loss from operations of USD 3.8 million. Cash and cash equivalents were USD 727.7 million, plus USD 15.3 million of current investments. Key risks include Margin pressure from medical costs, star rating outcomes that drive Medicare Advantage economics, and the guided fourth-quarter adjusted EBITDA loss.

Where Things Stand

Alignment Healthcare, Inc. (NASDAQ:ALHC) traded at USD 6.92 today, November 18, 2026, down 9.25% from a calculated prior close of USD 7.63, on volume of 1.16M shares. No catalyst was identified in published coverage. The latest reported quarter, ended September 30, 2026, showed revenue of USD 1,358.3 million, a net loss of USD 8.1 million, adjusted EBITDA of USD 21.8 million and cash of USD 727.7 million, while full-year adjusted EBITDA guidance was set at a minimum of USD 100 million. Medical cost trends, star ratings and the fourth-quarter outlook remain the principal variables, moves of this size can extend or reverse quickly, and this article is not Investment advice.